Abstract
Amphetamine anorexia in rats was potentiated by acute pretreatment with the tricyclic antidepressant desmethylimipramine (DMI), but was not significantly different from controls following chronic DMI pretreatment. During withdrawal from DMI, amphetamine anorexia was attenuated after 2 weeks or 2 months pretreatment, but not after 1 week of treatment. The locomotor stimulant and stereotypy inducing effects of amphetamine were slightly enhanced during withdrawal from chronic DMI. The results are discussed in relation to known neurochemical actions of DMI.
Similar content being viewed by others
References
Ahlskog JE (1974) Food intake and amphetamine anorexia after selective forebrain norepinephrine loss. Brain Res 82:211–240
Ahlskog JE, Hoebel BG (1973) Overeating and obesity from damage to a noradrenergic system in the brain. Science 182:166–169
Banerjee SP, Kung LS, Riggi SJ, Chanda SK (1977) Development of β-adrenergic receptor subsensitivity by antidepressants. Nature 268:455–456
Bloom FE, Siggins GR, Schultz JE, Henriksen SJ (1979) Catecholamine transmitter systems. In: Schoolar JL, Claghorn JL (eds) The kinetics of psychiatric drugs, Brunner/Mazel, New York, pp 63–75
Bradshaw CM, Roberts MHT, Szabadi E (1974) Effects of imipramine and desipramine on responses of single cortical neurons to noradrenaline and 5-hydroxytryptamine. Br J Pharmacol 52:349–358
Canguilhem B, Schmitt P, Mack G, Kempf E (1977) Comportement alimentaire, rythmes circannuel pondéral et d'hibernation chez le hamster d'Europe porteur de lésions des faisceaux noradrénergiques ascendants. Physiol Behav 18:1067–1074
Cole SO (1972) The relationship of amphetamine-induced anorexia and freezing under free-feeding conditions. Pharmacol Res Commun 4:71–76
Consolo S, Dolfini E, Garattini S, Valzelli L (1967) Desipramine and amphetamine metabolism. J Pharm Pharmacol 19:253–256
Creese I, Iversen SD (1973) Blockade of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res 55:369–382
Creese I, Iversen SD (1974) The role of forebrain dopamine systems in amphetamine induced stereotyped behaviour in the rat. Psychopharmacology 39:345–357
Frazer A, Mendels J (1977) Do tricyclic antidepressants enhance adrenergic transmission? Am J Psychiatry 134:1041–1042
Garattini S, Borroni E, Mennini T, Samanin R (1978) Differences and similarities among anorectic agents. In: Garattini S, Samanin R (eds) Central mechanisms of anorectic drugs. Raven Press, New York, pp 127–143
Glowinski J, Axelrod J (1964) Inhibition of the uptake of tritiated noradrenaline in the intact rat brain by imipramine and structurally related compounds. Nature 204:1318–1319
Gluckman MI, Baum T (1969) The pharmacology of iprindole, a new antidepressant. Psychopharmacology 15:169–185
Hoebel BG (1979) Hypothalamic self-stimulation and stimulation escape in relation to feeding and mating. Fed Proc 36:2454–2461
Huang YH (1979) Chronic desipramine treatment increases activity of noradrenergic postsynaptic cells. Life Sci 25:709–716
Jespersen S, Scheel-Kruger J (1973) Evidence for a difference in mechanism of action between fenfluramine- and amphetamine-induced anorexia. J Pharm Pharmacol 25:49–54
Kelly PH (1977) Drug induced motor behaviour. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol. 8. Plenum Press, New York and London, pp 295–331
Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 24:507–522
Kruk ZL, Millar J (1979) The effect of bilateral ventral noradrenaline bundle lesions on lever pressing for food in rats. Psychopharmacology 64:41–43
Leibowitz SF (1975) Catecholaminergic mechanisms of the lateral hypothalamus: their role in the mediation of ampetamine anorexia. Brain Res 98:529–545
Leibowitz SF (1978) Identification of catecholamine receptor mechanisms in the perifornical lateral hypothalamus and their role in mediating amphetamine and 1-DOPA anorexia. In: Garattini S, Samanin R (eds) Central mechanisms of anorectic drugs. Raven Press, New York, pp 39–82
Leibowitz SF, Rossakis C (1978) Analysis of feeding suppression produced by perifornical hypothalamic injection of catecholamines, amphetamine and mazindol. Eur J Pharmacol 53:69–81
Lemberger L, Sernatinger E, Kuntzman R (1970) Effect of desmethylimipramine, iprindole and DL-erythro-α (3,4-dichlorophenyl)-β-(t-butyl amino) propanol HCl on the metabolism of amphetamine. Biochem Pharmacol 19:3021–3028
Lewander T (1968) Effects of amphetamine on urinary and tissue catecholamines in rats after inhibition of its metabolism with desmethylimipramine. Eur J Pharmacol 5:1–9
Lorden J, Oltmans GA, Margules DL (1976) Central noradrenergic neurons: differential effects on body weight of electrolytic and 6-hydroxydopamine lesions in rats. J Comp Physiol Psychol 90:144–155
Maggi A, U'Prichard DC, Enna SJ (1980) Differential effects of antidepressant treatment on brain monoaminergic receptors. Eur J Pharmacol 61:91–98
Mason ST, Iversen SD (1979) Theories of the dorsal bundle extinction effect. Brain Res Rev 1:107–137
McMillen BA, Warnack W, German DC, Shore PA (1980) Effects of chronic desipramine treatment on rat brain noradrenergic responses to α-adrenergic drugs. Eur J Pharmacol 61:239–246
Menon MK, Subramanian K, Menon NK, Sharma SN (1970) Influence of desmethylimipramine on the appetite-lowering effects of d-amphetamine and other anorectics. Eur J Pharmacol 12:156–160
Modell W (1960) Status and prospects of drugs for overeating. JAMA 173:1132–1136
Oltmans GA, Lorden JF, Margules DL (1977) Food intake and body weight: effects of specific and non-specific lesions in the midbrain path of the ascending noradrenergic neurons of the rat. Brain Res 128:293–308
Pijenburg AJJ, Honig WMM, Rossum JM van (1975) Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat. Psychopharmacology 41:87–95
Raisman R, Briley M, Langer SZ (1979) High affinity 3H-imipramine binding in rat cerebral cortex. Eur J Pharmacol 54:307–308
Roffler-Tarlov S, Schildkraut JJ, Draskoczy PR (1973) Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monoamines in the rat brain. Biochem Pharmacol 22:2923–2926
Rosloff BN, Davis JD (1978) Decrease in brain NE turnover after chronic DMI treatment; no effect with iprindole. Psychopharmacology 56:335–341
Samanin R, Bendotti C, Bernasconi S, Pataccini R (1978) Differential role of brain monoamines in the activity of anorectic drugs. In: Garattini S, Samanin R (eds) Central mechanisms of anorectic drugs. Raven Press, New York, pp 233–242
Sanghvi IS, Singer G, Friedman E, Gershon S (1975) Anorexigenic effects of d-amphetamine and 1-DOPA in the rat. Pharmacol Biochem Behav 3:81–86
Schildkraut JJ (1975) Norepinephrine metabolism after short- and long-term administration of tricyclic antidepressant drugs and electroconvulsive shock. In: Mandell AJ (ed) Neurobiological mechanisms of adaptation and behaviour. Raven Press, New York, pp 137–153
Schildkraut JJ, Winokur A, Applegate CW (1970) Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine. Science 168:867–869
Schultz J (1976) Psychoactive drug effects on a system which generates cyclic AMP in Brain. Nature 261:417–418
Segal DS, Kuczenski R, Mandell AJ (1974) Theoretical implications of drug-induced adaptive regulation for a biogenic amine hypothesis of affective disorder. Biol Psychiatry 9:147–159
Sigg EB, Soffer L, Gyermek L (1963) Influence of imipramine and related psychoactive agents on effects of 5-hydroxytryptamine and catecholamines on the cat nictitating membrane. J Pharmacol Exp Ther 142:13–20
Sprott DA (1970) Note on Evans and Anastasio on the analysis of covariance. Psychol Bull 73:303–306
Sturman G (1970) Modification by a tricyclic series of compounds of the noradrenealine effect on the cat initiating membrane. J Pharm Pharmacol 23:142–143
Sulser F (1979) New perspectives on the mode of action of antidepressant drugs. TIPS 2:92–94
Sulser F, Owens ML, Dingell JV (1966) On the mechanism of amphetamine potentiation by desipramine (DMI). Life Sci 5:2005–2010
Svensson TH, Usdin T (1978) Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: α-receptor mediation. Science 202:1089–1091
Valzelli L, Consolo S, Morpurgo C (1967) Influence of imipramine-like drugs on the metabolism of amphetamine. In: Garattini S, Dukes MNG (eds) Proceedings of the first international symposium on antidepressant drugs. International Congress Series, No 122, Exerpta Medica, Amsterdam, pp 61–69
Vetulani J, Stawarz RJ, Sulser F (1976) Adaptive mechanisms of the noradrenergic cyclic AMP generating system in the limbic forebrain of the rat: adaptation to persistent changes in the availability of norepinephrine. J Neurochem 27:661–666
Willner P, Montgomery T (1980) Attenuation of amphetamine anorexia in rats following subchronic treatment with a tricyclic antidepressant. Commun Psychopharm 4:101–106
Willner P, Montgomery T, Bird D (1981) Behavioural changes during withdrawal from desmethylimipramine (DMI). II. Increased resistance to extinction. Psychopharmacology 75:60–64
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Willner, P., Montgomery, T. Behavioural changes during withdrawal from desmethylimipramine (DMI). Psychopharmacology 75, 54–59 (1981). https://doi.org/10.1007/BF00433502
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00433502